Home
Conditions
Recurrent Prostate Carcinoma

Clinical trial condition

Recurrent Prostate Carcinoma

Explore clinical trials studying Recurrent Prostate Carcinoma. Study availability and eligibility vary by location and protocol.

53 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Prostate Carcinoma trial results

Completed

Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy

NCT02099864

Conditions: Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +14 more
Locations: UCSF Medical Center-Mount Zion San Francisco, California, United States

OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer

NCT03698370

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations: Stanford Cancer Institute Palo Alto Palo Alto, California, United States

View Trial Details

Completed

Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer

NCT02499835

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +14 more
Locations: University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States

View Trial Details

Completed

Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

NCT02159950

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer

NCT03122743

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +13 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7

NCT02601014

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations: Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment

NCT02673151

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations: Stanford University, School of Medicine Palo Alto, California, United States

View Trial Details

Completed

Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T

NCT01833208

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

Western New York Urology Associates LLC-Harlem Cheektowaga, New York, United States

View Trial Details

Completed

Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy

NCT02940262

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Completed

Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

NCT01503229

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recurrent Prostate Carcinoma

Recurrent Prostate Carcinoma trial results

Related conditions